| PRENATAL LABS |
Initial Visit |
Routine Labs: Type & Screen, CBC, HBsAg, RPR, Rub, U/A c micro, C&S, Pap, G/C probe, (Sickle Cell if black, 1H GCT if risk factors) |
15-20 wks |
Triple Screen offered |
18-21 wks |
Initial Sonogram/Level 2 Sono if indicated |
24-28 wks |
1h GCT (abnl if >130), Tubal counseling if indicated |
32-34 wks |
H/H, HBsAg, RPR |
32-40 wks |
If DM/Multiple Gestation/chronic HTN, then weekly NST |
35-37 wks |
GBS |
37 wks |
If DM, Sonogram |
>41 wks |
AFI and NST, if any problem to L&D for eval of induction |

| Diabetes Screening Guidelines |
| Needs Initial Visit Screening (1h GCT) if: |
- Obese (>=20% IBW or BMI>=29 prepregnancy weight)
IBW =100lbs 1st 5 feet, then 5lbs for each inch over 5 feet
Use current body weight with max ADA diet of 2800-3000 calories.
|
- H/o GDM
|
- H/o stillbirth
|
- H/o macrosomia >=4000 gm
|
- H/o fetus w/ congenital anomalies
|
- Family history of DM in 1st degree relative
|
| Screening: 1h GCT >/=130 |
| |
| Diagnosis & Classification |
Diagnosis |
Classification of DM
in pregnancy
|
Target glucose
(GOOD glucose control) |
| 3º GTT - fasting overnight |
A1 |
FBS < 95 mg/dl ->diet x 2wks |
FBS < 95 mg/dl
|
| Abnormal is 2 or more abnormal values |
A2 |
FBS > 95 mg/dl ->insulin |
Pre meal <105
|
FBS
1º
2º
3º
|
>95mg/dl
>180
>155
>140 |
B |
onset > 20 yo, duration <10 yrs |
Post meal <115
|
C |
onset 10-19 yo, duration 10-19 yrs |
Average <105
|
D |
onset <= 10 yo, duration >=20 yrs, or Benign retinopathy |
RPD >/= 4
|
F |
nephropathy |
2º post prandial <115 mg/dl
|
| |
H |
heart disease |
Average is equal to total glucose/ # of Accu-Cheks done in 24h (when in hospital
|
| |
RT |
renal transplant |
|
| |
DIABETES TREATMENT OPTIONS |
Exercise:
- Walk 2 miles/day
- Health Club
- Swim 2/3 miles/day
Diet:
- Ideal Body Weight (IBW) = 100 lbs 1st 5 feet, then 5 lbs for each inch
- Abnormal 3º - START Low Carb diet x 2 weeks
- ADA Diet: 40% carbo, 35% protein, 20% fat
Max 2800-3000 calories
Min 1800 calories
- If Obese (BMI >29) then give 25 kcal/kg of IBW
- If Normal (BMI 20-26) then give 30 kcal/kg of IBW
- If Underweight (BMI <20) then give 35 kcal/kg of IBW
Other method of ADA diet is use current body weight with max ADA diet of 2800-3000 calories.
Desired wt gain: (Weeks gestation - 12) x 0.9 = desirable wt
- 0-12 weeks - 0 lb/wk gain
- 13-26 weeks - 0.9 lbs/wk gain
- 27-40 weeks - 0.9 lbs/wk gain
Oral Agent:
- x > 200 mg/dl/wk -> insulin
- x < 200 mg/dl/wk -> GLYBURIDE start with 2.5 mg (Evaluate q wk)
|
start |
next |
next |
next |
max |
AM |
2.5 |
5 |
5 |
10 |
10 |
PM |
|
|
5 |
5 |
10 |
Insulin:
- 30 min before breakfast and 30 min before dinner
- Initial dose 0.7 - 1.0 U/kg/day
- 2/3 in am, 1/3 in pm
- AM: 1/3 Reg, 2/3 NPH
- PM: 1/2 Reg, 1/2 NPH
Dosing |
AM |
5PM |
Reg |
1/3 |
1/2 |
NPH |
2/3 |
1/2 |
| Time of Action |
Reg |
30 min - >2 hrs |
NPH |
6 hr - >12 hrs |
| Blood glucose adjustment |
| |
< 80 |
Decrease 1-2 U |
| |
140-200 |
Increase 1 U |
| |
201-250 |
Increase 2 U |
| |
251-300 |
Increase 3 U |
| |
> 301 |
Increase 4 U |
If Hyperglycemia: Majority BG elevated - increase total insulin 20%
- 1-2 BG elevated - increase corresponding dose by 10%
- FBG >95 - increase pm NPH by 10-20%
|
If Hypoglycemia:
- FBG <60 - decrease pm NPH by 10%
- Pre-supper/post prandial <60 - decrease pm Reg by 10%
|
Pregestional DM then order:
- HbA1C - initial intake and at 32 wks
- Fasting Lipid Profile (FLP), TSH
- Kidney Profile - creatine clearance, uric acid, urea, microalbumin (each trimester)
- C peptide
- Eye exam - initial and 3rd trimester
- EKG
- Sonogram: Initial visit
- Level II at 26-30 wks
- 37 wks
- NST: Weekly after 32 wks
Fetal Growth:
- 30 gm/day - good control
- 60 gm/day - poor control

Some indications for urodynamic testing include:
- Stress / Urge / Mixed Incontinence
- Complete Procidentia, Cystocele, Rectocele
- Incomplete emptying
- Symptoms with hx of previous incontinence surgery, XRT, or radical pelvic surgery
Before starting Uroflow testing, check name, consent and urine culture. If + culture, treat infection and reschedule patient (preferably before clinic day).
Urodynamics Procedure: Sterile prep done, place catheter in urethra and catheter in vagina. Start flow with 100ml/min. Pt to report when she feels her FIRST SENSATION to use the rest room and when she HAS to immediately go to the restroom ( TOTAL CAPACITY) . Pt also is asked to cough at each 100ml filling. Once pt reaches her TOTAL CAPACITY, she is asked to cough. To test for detrusor instability, the sound of water running is made by pouring water from one jar to another and/or the pt’s hand is placed in the water.
Write NAME and DATE on PRINT OUT
Reading the PRINT OUT (Graph):
- Uroflow ( box = sec)
- Cystometrogram (CMG)
- Pressure Abdomen (Pa)
- Pressure Detrusor (Pd)
- Pressure Urethra (Pu)
- Urethral Closure Pressure (Ucp) = (Pu-Pb) = 0.5cm /block -horizontally, 20cm H20/box -vertical)
What is Synchronous Void?:
Relax in urethral pressure with concomitant increase in abdominal pressure and/or increase in detrusor pressure.
URODYNAMIC PEARLS
- Average 1st sensation – 150ml
- Average Total Sensation- 350
- Average Post Void Residual- <50ml or 80% of total (UOP and residual)
URODYNAMICS- SAMPLE NOTE
- Uroflow:
- VV (volume voided): 400 ml,
- PVR (post void residual) 40 ml,
- Qmax (max flow)- 22 ml/sec,
- TIME (11 sec)
- CMG (Cystometrogram):
- 1st sensation: 150 ml
- TC (Total Capacity): 350 ml
- DI (Detrusor Instability): No
- Leak: No
- UPP (Urethral Pressure Profile)
- FUL (functional urethral length) – 1.5 mm (each block is 5mm)
(length where urethral pressure exceeds intravesical pressure)
- MUCP (measured urethral closure pressure – 170cm H2O (each block is 20cm H2O)
- PE (pressure equalization) – Yes
(Signifies genuine stress incontinence - in the absence of a detrusor contraction)
- Leak - Yes
- Voiding Study
Assessment: Cystocele/Rectocele, Genuine Stress Incontinence
Plan: a) F/U with Pre OP clinic and
b) UTI prophylaxis: Macrobid 1 po this am and pm.

|
|
Diagnoses |
Tests |
Therapies |
Multifactorial
40% |
Semen analysis, Midluteal serum progesterone, laparoscopy, HSG |
See individual tests |
Treat one or more specific factors |
Endometriosis
17% |
Laparoscopy |
Characteristic implant and adhesions |
Prospective observation, conservative resection at laparotomy |
Male Factor
12% |
Semen Analysis |
<20 million normal motile sperm |
Prospective observation or donor insemination |
Ovulatory Dysfunction
11% |
Midluteal serum progesterone, late luteal endometrial biopsy |
Progesterone <15ng/ml |
Clomiphene |
Tubal Factor/Pelvic Adhesions
8% |
Laparoscopy with hydrotubation, HSG |
Tubal occlusion, adhesions |
Laser laparoscopy or lysis of adhesions, tuboplasties |
Cervical Factor
1% |
Postcoital test |
<5 motile sperm/hpf in late follicular phase mucus |
Prospective observation |
Uterine Factor
1% |
Hysteroscopy, HSG |
Septum, polyp, fibroid |
Hyteroscopic resection |
Idiopathic
10% |
Semen analysis, Midluteal serum progesterone, laparoscopy, HSG |
See individual tests |
Prospective observation, Empirical clomiphene or antibiotics |

|